hcas9 expression vector (Addgene inc)
Structured Review
Hcas9 Expression Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 679 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hcas9+expression+vector/hCas9+(Plasmid+%2341815)/pm41904535-59-1-7
Average 96 stars, based on 679 article reviews
Images
Related Articles
Expressing:Article Title: TMEPAI/PMEPA1 inhibits Wnt signaling by regulating β-catenin stability and nuclear accumulation in triple negative breast cancer cells. Article Snippet: Accepted Manuscript TMEPAI/PMEPA1 inhibits Wnt signaling by regulating β-catenin stability and nuclear accumulation in triple negative breast cancer cells Riezki Amalia, Mohammed Abdelaziz, Meidi Utami Puteri, Jongchan Hwang, Femmi Anwar, Yukihide Watanabe, Mitsuyasu Kato PII: S0898-6568(19)30059-2 DOI: https://doi.org/10.1016/j.cellsig.2019.03.016 Reference: CLS 9291 To appear in: Cellular Signalling Received date: 11 December 2018 Revised date: 15 March 2019 Accepted date: 15 March 2019 Please cite this article as: R. Amalia, M. Abdelaziz, M.U.. Puteri, et al., TMEPAI/PMEPA1 inhibits Wnt signaling by regulating β-catenin stability and nuclear accumulation in triple negative breast cancer cells, Cellular Signalling, https://doi.org/10.1016/ j.cellsig.2019.03.016 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript. Article Title: PMEPA1/TMEPAI isoforms function via its PY and Smad-interaction motifs for tumorigenic activities of breast cancer cells. Article Snippet: .. We thank Dr. George Church for kindly providing us gRNA_Cloning Vector (Addgene #41824) and Article Title: Reconstruction of enhancer-target networks in 935 samples of human primary cells, tissues and cell lines. Article Snippet: VOLUME 49 | NUMBER 10 | OctOBER 2017 Nature GeNetics We propose a new method for determining the target genes of transcriptional enhancers in specific cells and tissues.. It combines global trends across many samples and sample-specific information, and considers the joint effect of multiple enhancers.. Our method outperforms existing methods when predicting the target genes of enhancers in unseen samples, as evaluated by independent experimental data. Article Title: Identification of an enhancer region within the TP63 / LEPREL1 locus containing genetic variants associated with bladder cancer risk Article Snippet: .. At 70–80% confluency the cells were co-transfected with a Article Title: Article Snippet: .. The CMV-driven Cas9 gene was PCR amplified from the Article Title: A rapid and highly sensitive CRISPR-Cas12a ortholog-assisted assay for genotyping of myostatin knockout pigs. Article Snippet: .. The Article Title: In Vitro and In Vivo Synergistic Therapeutic Effect of Cisplatin with Human Papillomavirus16 E6/E7 CRISPR/Cas9 on Cervical Cancer Cell Line Article Snippet: .. The Article Title: Inhibition of long non-coding RNA UCA1 by CRISPR/Cas9 attenuated malignant phenotypes of bladder cancer Article Snippet: .. The Plasmid Preparation:Article Title: TMEPAI/PMEPA1 inhibits Wnt signaling by regulating β-catenin stability and nuclear accumulation in triple negative breast cancer cells. Article Snippet: Accepted Manuscript TMEPAI/PMEPA1 inhibits Wnt signaling by regulating β-catenin stability and nuclear accumulation in triple negative breast cancer cells Riezki Amalia, Mohammed Abdelaziz, Meidi Utami Puteri, Jongchan Hwang, Femmi Anwar, Yukihide Watanabe, Mitsuyasu Kato PII: S0898-6568(19)30059-2 DOI: https://doi.org/10.1016/j.cellsig.2019.03.016 Reference: CLS 9291 To appear in: Cellular Signalling Received date: 11 December 2018 Revised date: 15 March 2019 Accepted date: 15 March 2019 Please cite this article as: R. Amalia, M. Abdelaziz, M.U.. Puteri, et al., TMEPAI/PMEPA1 inhibits Wnt signaling by regulating β-catenin stability and nuclear accumulation in triple negative breast cancer cells, Cellular Signalling, https://doi.org/10.1016/ j.cellsig.2019.03.016 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript. Article Title: Reconstruction of enhancer-target networks in 935 samples of human primary cells, tissues and cell lines. Article Snippet: VOLUME 49 | NUMBER 10 | OctOBER 2017 Nature GeNetics We propose a new method for determining the target genes of transcriptional enhancers in specific cells and tissues.. It combines global trends across many samples and sample-specific information, and considers the joint effect of multiple enhancers.. Our method outperforms existing methods when predicting the target genes of enhancers in unseen samples, as evaluated by independent experimental data. Article Title: Identification of an enhancer region within the TP63 / LEPREL1 locus containing genetic variants associated with bladder cancer risk Article Snippet: .. At 70–80% confluency the cells were co-transfected with a Article Title: Article Snippet: .. The CMV-driven Cas9 gene was PCR amplified from the Article Title: A rapid and highly sensitive CRISPR-Cas12a ortholog-assisted assay for genotyping of myostatin knockout pigs. Article Snippet: .. The Article Title: In Vitro and In Vivo Synergistic Therapeutic Effect of Cisplatin with Human Papillomavirus16 E6/E7 CRISPR/Cas9 on Cervical Cancer Cell Line Article Snippet: .. The Article Title: Inhibition of long non-coding RNA UCA1 by CRISPR/Cas9 attenuated malignant phenotypes of bladder cancer Article Snippet: .. The Knock-Out:Article Title: Reconstruction of enhancer-target networks in 935 samples of human primary cells, tissues and cell lines. Article Snippet: VOLUME 49 | NUMBER 10 | OctOBER 2017 Nature GeNetics We propose a new method for determining the target genes of transcriptional enhancers in specific cells and tissues.. It combines global trends across many samples and sample-specific information, and considers the joint effect of multiple enhancers.. Our method outperforms existing methods when predicting the target genes of enhancers in unseen samples, as evaluated by independent experimental data. Transfection:Article Title: Reconstruction of enhancer-target networks in 935 samples of human primary cells, tissues and cell lines. Article Snippet: VOLUME 49 | NUMBER 10 | OctOBER 2017 Nature GeNetics We propose a new method for determining the target genes of transcriptional enhancers in specific cells and tissues.. It combines global trends across many samples and sample-specific information, and considers the joint effect of multiple enhancers.. Our method outperforms existing methods when predicting the target genes of enhancers in unseen samples, as evaluated by independent experimental data. Article Title: Identification of an enhancer region within the TP63 / LEPREL1 locus containing genetic variants associated with bladder cancer risk Article Snippet: .. At 70–80% confluency the cells were co-transfected with a Clone Assay:Article Title: Reconstruction of enhancer-target networks in 935 samples of human primary cells, tissues and cell lines. Article Snippet: VOLUME 49 | NUMBER 10 | OctOBER 2017 Nature GeNetics We propose a new method for determining the target genes of transcriptional enhancers in specific cells and tissues.. It combines global trends across many samples and sample-specific information, and considers the joint effect of multiple enhancers.. Our method outperforms existing methods when predicting the target genes of enhancers in unseen samples, as evaluated by independent experimental data. Selection:Article Title: Reconstruction of enhancer-target networks in 935 samples of human primary cells, tissues and cell lines. Article Snippet: VOLUME 49 | NUMBER 10 | OctOBER 2017 Nature GeNetics We propose a new method for determining the target genes of transcriptional enhancers in specific cells and tissues.. It combines global trends across many samples and sample-specific information, and considers the joint effect of multiple enhancers.. Our method outperforms existing methods when predicting the target genes of enhancers in unseen samples, as evaluated by independent experimental data. Polymerase Chain Reaction:Article Title: Article Snippet: .. The CMV-driven Cas9 gene was PCR amplified from the Amplification:Article Title: Article Snippet: .. The CMV-driven Cas9 gene was PCR amplified from the Introduce:Article Title: Article Snippet: .. The CMV-driven Cas9 gene was PCR amplified from the Cloning:Article Title: In Vitro and In Vivo Synergistic Therapeutic Effect of Cisplatin with Human Papillomavirus16 E6/E7 CRISPR/Cas9 on Cervical Cancer Cell Line Article Snippet: .. The Article Title: Inhibition of long non-coding RNA UCA1 by CRISPR/Cas9 attenuated malignant phenotypes of bladder cancer Article Snippet: .. The |

![Establishment of IL-17RA-deficient AX cells. ( a ) Two independent IL-17RA-deficient AX lines (KO1 and KO2) were generated by <t>lentiviral</t> transduction using the CRISPR/Cas9 system. AX cells transduced with scramble constructs served as controls (AX-SCR). IL-17RA expression on these AX cell lines, which harbor a GFP tag, was analyzed by flow cytometry. Solid or dotted lines in histograms represent AX cells stained with anti-IL-17RA or isotype control antibody, respectively. ( b ) IL-17RA-deficient and control AX cells (Parental AX cells and AX-SCR) were cultured 24 h with or without (vehicle) IL-17A (500 ng/ml) and the number of AX cells was analyzed by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay measuring absorbance at 570 nm. Data represent mean absorbance ± s.d. (n = 6, * P < 0.05). ( c ) IL-17RA knockout (middle and bottom rows) or scramble-transduced AX cells (top row) were treated with or without (vehicle) IL-17A (500 ng/ml). After 24 h, total RNA was prepared, and expression of ALP , Oc or Runx2 relative to β-actin was analyzed by quantitative real-time PCR. Data represent mean indicated gene expression relative to β-actin ± s.d. (n = 6, * P < 0.05). ( d ) IL-17RA knockout (middle and right rows) or scramble-transduced AX cells (left rows) were treated with or without (vehicle) IL-17A (500 ng/ml). After 48 h, total protein was extracted, and ALP, Oc and Runx2 levels were analyzed by western blot. The graph shows the normalization of ALP, Oc and Runx2 levels to total Actin levels (* P < 0.05, n = 3).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_3823/pmc10703823/pmc10703823__41598_2023_49016_Fig5_HTML.jpg)